References

Acupuncture Allergies Alzheimer's Disease Androgen Anxiety Disorders Asthma Atherosclerosis Attention Deficit Hyperactivity Disorder Bacterial Vaginosis Biofeedback Bipolar Disorder Birth Control Pills Blood Donation and Transfusion Breast Augmentation and Reduction Breast Cancer Breastfeeding Breast Reconstruction Caregiving Cervical Cancer Chiropractic Chlamydia Cholesterol Chronic Fatigue Syndrome Clinical Trials Colon Cancer Contraception Depression Diabetes Dry Eye Syndrome Eating Disorders Endometriosis Epilepsy Estrogen Fibroids Fibromyalgia Fitness Flu/Colds Gastroesophageal Reflux Disease (GERD) Genetic Testing Genital Herpes Glaucoma Gonorrhea Health Insurance Heart Disease Hepatitis High Blood Pressure HIV/AIDS Homeopathy Human Papillomavirus Hypnosis Hysterectomy Incontinence Infertility Irritable Bowel Syndrome Legal Health Tools Liposuction Lung Cancer Lupus Macular Degeneration Medication Safety Menopause Menstrual Disorders Metabolic Syndrome Migraine Multiple Sclerosis Naturopathy Nonsurgical Aesthetic Procedures Nutrition Obesity Ocular Allergies Oral Health Osteoarthritis Osteopathic Medicine Osteoporosis Ovarian Cancer Overactive Bladder Pain Management Pelvic Organ Prolapse Pelvic Pain Peripheral Arterial Disease Polycystic Ovary Syndrome Pregnancy Premenstrual Syndrome Preparing for Surgery Progesterone Rheumatoid Arthritis Schizophrenia Scleroderma Sexual Dysfunction Sinusitis Sjogren's Syndrome Skin Cancer Skin Health Sleep Disorders Smoking Stress Stroke Substance Abuse Tai Chi Teen Health Thyroid Disorders Trichomoniasis Urinary Tract Conditions Urinary Tract Infection Uterine Cancer Varicose Veins Violence Against Women Vulvodynia Weight Management Yeast Infections Yoga

FDA Approves Lower Dose of Prempro, A Combination Estrogen and Progestin Drug for Postmenopausal Women. Press Release, March 13, 2003. http://www.fda.gov

"FDA Approves New Labels for Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women Following Review of Women's Health Initiative Data." FDA News/Press Release. January 8, 2003. http://www.fda.gov. Accessed Dec. 2003.

Lacey, James V., et al. "Menopausal Hormone Replacement Therapy and Risk of Ovarian Cancer." JAMA 2002. Vol. 288:334-341.368-369.

Grady D, Herrington D, Bittner V, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 1. Cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:49-57.

Hulley S, Furberg C, Barrett-Connor E, et al, for the HERS Research Group. Heart and estrogen/progestin replacement study follow-up (HERS II): Part 2. Non-cardiovascular outcomes during 6.8 years of hormone therapy. JAMA 2002;288:58-66.

Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.

"Women's Health Initiative," National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Updated Oct. 2003; accessed Dec. 2003.

The Menopause Guidebook: Helping Women Make Informed Healthcare Decisions through Perimenopause and Beyond. North American Menopause Society: May 2003; http://www.menopause.org. Accessed Dec. 2003.

About genetics services (overview material). GeneTests (Collaborative effort of the NIH, HHS, University of Washington and Children's Hospital and Regional Medical Center of Seattle). Revised 2000. http://www.genetests.org. Accessed Jan. 2002.

Genzyme Genetics patient information: Conditions and Tests. http://www.genzymegenetics.com. Accessed Dec. 2003.

Ashkenazi Jewish Genetic Diseases. Albert Einstein Health Care Network. Updated Sept. 2001. http://www.einstein.edu. Accessed Dec. 2003.

Burke, Wylie, E Thomas, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. Journal of the American Medical Association. July 8, 2000; Vol. 280, pp. 172-78.

Celiac Disease. National Institute of Diabetes and Digestive and Kidney Disease. July 2003. http://www.niddk.nih.gov. Accessed Dec. 2003.

Facts About Cystic Fibrosis. National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Accessed Jan. 2002.

Facts about Fragile X Syndrome. National Institute of Child Health and Human Development. Last modified Nov. 2002. http://www.nichd.nih.gov. Accessed Dec. 2003.

Facts About Sickle Cell Anemia. National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Accessed Jan. 2002.

Multiple Endocrine Neoplasia Type 1. National Institute of Diabetes and Digestive and Kidney Diseases. Last reviewed June 2002. http://www.niddk.nih.gov. Accessed Dec. 2003.

Hemochromatosis. National Institute of Diabetes and Digestive and Kidney Disease. Aug. 2002. http://digestive.niddk.nih.gov. Accessed Dec. 2003.

Huntington's Disease. National Institute of Neurological Disorders and Stroke. Last reviewed July 2001. http://www.ninds.nih.gov. Accessed Jan. 2002.

Neurofibromatosis. National Institute of Neurological Disorders and Stroke. Reviewed May 2003. http://www.ninds.nih.gov. Accessed Dec. 2003.

NHGRI Glossary of Genetic Terms. National Human Genome Research Institute. http://www.genome.gov. Accessed Dec. 2003.

NINDS von Hippel Lindau Disease Information Page. National Institute of Neurological Disorders and Stroke. Reviewed May 2002. http://www.ninds.nih.gov. Accessed Dec. 2003.

Understanding Alpha-1 Antitrypsin Deficiency. National Heart, Lung and Blood Institute. http://www.nhlbi.nih.gov. Accessed Jan. 2002.

MEDLINEplus: Alpha-1 Antitrypsin Deficiency. Updated Jan. 2002. http://www.nlm.nih.gov. Accessed Jan. 2002.

Understanding Gene Testing. National Cancer Institute. http://www.accessexcellence.org. Accessed Jan. 2002.